M F Kohler

770 total citations
9 papers, 622 citations indexed

About

M F Kohler is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M F Kohler has authored 9 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M F Kohler's work include Cancer Treatment and Pharmacology (3 papers), Cancer therapeutics and mechanisms (2 papers) and Estrogen and related hormone effects (2 papers). M F Kohler is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), Cancer therapeutics and mechanisms (2 papers) and Estrogen and related hormone effects (2 papers). M F Kohler collaborates with scholars based in United States, France and Germany. M F Kohler's co-authors include Peter A. Humphrey, Robert C. Bast, Andrew Berchuck, Jeffrey R. Marks, B. J. Kerns, Billie‐Jo Kerns, Hiroshi Sasaki, Y. Terashima, Regina S. Whitaker and G P Siegal and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Journal of Histochemistry & Cytochemistry and Gynecologic Oncology.

In The Last Decade

M F Kohler

9 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M F Kohler United States 7 280 263 195 168 133 9 622
H Nishii Japan 9 171 0.6× 138 0.5× 175 0.9× 97 0.6× 101 0.8× 15 490
Hyun S. Shvartsman United States 9 438 1.6× 194 0.7× 355 1.8× 86 0.5× 81 0.6× 10 785
Charles R. Boice United States 10 458 1.6× 137 0.5× 191 1.0× 120 0.7× 85 0.6× 12 648
Yasunori Hashiguchi Japan 14 196 0.7× 229 0.9× 236 1.2× 80 0.5× 64 0.5× 37 549
W. Kleine Germany 10 189 0.7× 124 0.5× 73 0.4× 126 0.8× 55 0.4× 33 449
Richard A. Boothby United States 6 291 1.0× 323 1.2× 183 0.9× 41 0.2× 120 0.9× 7 600
Ingirídur Skírnisdóttir Sweden 16 499 1.8× 234 0.9× 176 0.9× 107 0.6× 87 0.7× 26 682
Fumitoshi Terauchi Japan 10 511 1.8× 211 0.8× 142 0.7× 113 0.7× 64 0.5× 31 716
Malti Kshirsagar United States 9 125 0.4× 218 0.8× 201 1.0× 176 1.0× 92 0.7× 9 603
Hiroaki Kase Japan 16 453 1.6× 94 0.4× 167 0.9× 105 0.6× 81 0.6× 35 834

Countries citing papers authored by M F Kohler

Since Specialization
Citations

This map shows the geographic impact of M F Kohler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M F Kohler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M F Kohler more than expected).

Fields of papers citing papers by M F Kohler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M F Kohler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M F Kohler. The network helps show where M F Kohler may publish in the future.

Co-authorship network of co-authors of M F Kohler

This figure shows the co-authorship network connecting the top 25 collaborators of M F Kohler. A scholar is included among the top collaborators of M F Kohler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M F Kohler. M F Kohler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Fradin, Mélanie, Corinne Stoetzel, Jean Muller, et al.. (2010). Osteosclerotic bone dysplasia in siblings with a Fam20C mutation. Clinical Genetics. 80(2). 177–183. 56 indexed citations
2.
Look, Katherine Y., et al.. (1998). A Phase II Trial of CPT-11 in Recurrent Squamous Carcinoma of the Cervix: A Gynecologic Oncology Group Study. Gynecologic Oncology. 70(3). 334–338. 44 indexed citations
3.
Sasaki, Hiroshi, H Nishii, Hirotaka Takahashi, et al.. (1993). Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma.. PubMed. 53(8). 1906–10. 133 indexed citations
4.
Kohler, M F, B. J. Kerns, Peter A. Humphrey, et al.. (1993). Mutation and overexpression of p53 in early-stage epithelial ovarian cancer.. PubMed. 81(5 ( Pt 1)). 643–50. 144 indexed citations
5.
Kerns, B. J., M B Moore, Peter A. Humphrey, et al.. (1992). p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry.. Journal of Histochemistry & Cytochemistry. 40(7). 1047–1051. 96 indexed citations
6.
Bauknecht, Thomas, et al.. (1992). Expression analysis of EGF-R and TGFa in human ovarian carcinomas.. PubMed. 11(4). 1523–8. 14 indexed citations
7.
Jacobs, Ian, M F Kohler, Roger W. Wiseman, et al.. (1992). Clonal Origin of Epithelial Ovarian Carcinoma: Analysis by Loss of Heterozygosity, p53 Mutation, and X-Chromosome Inactivation. JNCI Journal of the National Cancer Institute. 84(23). 1793–1798. 129 indexed citations
8.
McWhirter, K M, et al.. (1987). Phase II evaluation of oral medroxyprogesterone acetate in advanced breast cancer: a Northern California Oncology Group Study.. PubMed. 71(10). 969–70. 1 indexed citations
9.
Me, Billingham, et al.. (1987). Esorubicin in refractory metastatic carcinoma of the breast: a Northern California Oncology Group Study.. PubMed. 71(4). 427–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026